Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Podrobná bibliografie
Hlavní autoři: Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
Médium: Journal article
Vydáno: 2009